Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Clinica Baviera S.A. | 2 | 0 | 0 | 0 | €28.60 | - | - |
| Insulet Corp. | 14 | 0 | 1 | 0 | €162.10 | €215.54 | 32.966% |
| Masimo Corp. | 7 | 1 | 2 | 0 | €127.05 | €147.62 | 16.187% |
| EyePoint Pharmaceuticals Inc. | 14 | 1 | 0 | 1 | €18.33 | €28.17 | 53.670% |
| Owens & Minor Inc. | 2 | 1 | 0 | 0 | €22.20 | €24.04 | 8.298% |
| Smith & Nephew plc ADR | 2 | 0 | 0 | 0 | €22.40 | - | - |
| PharmAust Ltd. | 1 | 0 | 0 | 0 | €0.11 | - | - |
| Codexis Inc. | 5 | 2 | 1 | 0 | €3.65 | €8.36 | 129.161% |
| Horizon Pharma plc | 7 | 0 | 0 | 0 | €110.40 | - | - |
| PTC Therapeutics Inc. | 14 | 5 | 3 | 0 | €31.00 | €41.51 | 33.911% |
| Agios Pharmaceuticals Inc. | 5 | 0 | 2 | 0 | €30.60 | €38.99 | 27.414% |
| Radnet Inc. | 7 | 3 | 0 | 0 | €47.60 | €50.90 | 6.926% |
| Glycomimetics Inc. | 5 | 0 | 0 | 0 | €1.71 | €7.35 | 330.926% |
| Cara Therapeutics Inc. | 8 | 1 | 1 | 0 | €0.72 | €4.63 | 541.177% |
| Intra-Cellular Therapies Inc. | 23 | 0 | 7 | 0 | €64.00 | €79.43 | 24.109% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 4 | 0 | €39.80 | €84.74 | 112.925% |
| Akebia Therapeutics Inc. | 8 | 3 | 1 | 0 | €1.28 | €3.60 | 181.840% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.87 | - | - |
| Affimed N.V. | 8 | 6 | 0 | 0 | €0.55 | €6.54 | 1083.165% |
| Abeona Therapeutics Inc. | 3 | 1 | 1 | 0 | €4.28 | €34.41 | 704.033% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €128.00 | €150.00 | 17.188% |
| Cosmo Pharmaceuticals S.A. | 1 | 0 | 0 | 0 | €74.50 | - | - |
| M1 Kliniken AG | 2 | 0 | 0 | 0 | €15.75 | - | - |
| Aclaris Therapeutics Inc | 1 | 0 | 1 | 0 | €1.26 | €3.00 | 138.284% |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |